7 September 2026

1. Introduction

On 24 July 2026, The Stock Exchange of Hong Kong Limited (the “Exchange”), a wholly-owned subsidiary of the Hong Kong Exchanges and Clearing Limited (“HKEX”), published the consultation conclusions (the “Consultation Conclusions”) on their consultation paper on the Listing Framework Competitiveness Review. This marks the initial phase of the Exchange’s competitiveness review of Hong Kong’s listing framework, seeking market feedback on targeted reforms aimed at broadening company diversity, expanding investment opportunities, and maintaining robust investor protections.

The proposals aim to reform the existing environment primarily by refining the existing listing framework in three vital areas:

1. Expanding the Weighted Voting Rights (WVR) regime by lowering market capitalisation and financial eligibility thresholds and relaxing certain WVR restrictions to enhance market competitiveness.
2. Altering the regime to support overseas-listed issuers, which includes introducing measures to facilitate overseas issuers’ listings in Hong Kong and lowering the eligibility thresholds for secondary listings. This lowers the barrier for overseas issuers to access the Hong Kong market and strengthens Hong Kong’s competitiveness as an international listing venue.
3. Enhancing initial listing requirements and arrangements to streamline the listing process and improve the protection of commercially sensitive information. This is done by improving the listing pathway for commercialised biotech and specialist technology companies, expanding the scope of confidential filing of listing applications to cover all new applicants, and refining the return mechanism.

2. The key proposals to be adopted

3.Conclusion

The relevant Listing Rule amendments became effective immediately upon publication of the Consultation Conclusions on 24 July 2026.

The reforms hold significant relevance to all companies considering applying for a listing on the Exchange, particularly those in biotech and technology sectors. Significantly, listing applicants are advised to take into account the following:

1. The reduction in the market capitalisation thresholds for WVR companies will enable more mid-sized technology and innovative companies to list on the Exchange with a WVR structure.
2. The formalisation of two pathways for satisfying the innovative company requirement, namely a technology-based route (Route A) and a business model-based route (Route B), provides greater certainty and a clearer pathway for different types of innovative companies seeking a WVR listing.
3. Biotech and specialist technology companies that already meet the financial eligibility tests are given the option to list under the applicable specialist chapters, providing a wider range of choices to listing applicants.
4. The expansion of the non-public filing regime to all new applicants, together with the enhanced Return Mechanism, is expected to provide greater flexibility during the IPO process while increasing accountability among professional advisers involved in listing applications.

The Exchange has indicated that these reforms represent the first phase of its competitiveness review, with further consultations and potential reforms to the listing framework expected in due course.

Please contact our Partner Mr. Rodney Teoh for any enquiries or further information.

This news update is for information purposes only. Its content does not constitute legal advice and should not be treated as such. Stevenson, Wong & Co. will not be liable to you in respect of any special, indirect or consequential loss or damage arising from or in connection with any decision made, action or inaction taken in reliance on the information set out herein.

7 September 2026

1.    Introduction

On 21 August 2026, The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), a wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited (the “HKEX”), announced the implementation of a temporary waiver under which the validity period of eligible new listing applications will be extended from six months to twelve months from the date of submission of the listing application form, subject to certain conditions and safeguards (the “Temporary Waiver”). The Temporary Waiver will apply for a period of three years from the date of the announcement, namely from 21 August 2026 to 20 August 2029.

2.    Key Features of the New Measure

According to the Stock Exchange’s announcement, the Temporary Waiver applies to all new listing applications that satisfy the conditions set out in the announcement, including: (a) listing applications that remained valid as of 21 August 2026 (being the date of the announcement); and (b) listing applications submitted or re-submitted on or after 21 August 2026. To qualify for the Temporary Waiver, the following conditions must be met:

• the Stock Exchange must not have stated in its comment letter that the review of the applicant’s new listing application has been suspended; and
• the Securities and Futures Commission (the “SFC”) and/or the Stock Exchange must not have issued a direct request for information letter and/or a material comment letter to the applicant.

Where the concerns identified in such regulatory correspondence have been satisfactorily addressed and accepted by the relevant regulator before the expiry of the initial six-month validity period, the relevant listing application may still qualify for the Temporary Waiver.

Applicants benefiting from the extended validity period must continue to comply with all applicable Listing Rules and provide complete and up-to-date information, including updated business and financial information, to enable regulators to properly assess each application and investors to make informed decisions. The extension does not alter the Stock Exchange’s existing regulatory standards or investor protection measures. The Stock Exchange will monitor the implementation and effectiveness of the Temporary Waiver and may review the relevant requirements or conduct a public consultation if considered necessary and appropriate.

3.    Enhancing Flexibility and Reducing Repetitive Work

The Temporary Waiver is designed to provide applicants, sponsors and their advisers with greater flexibility in managing listing timetables, while reducing the frequency of re-submissions and the associated burden of repeatedly updating application documents and supporting materials. This allows market participants to focus more effectively on maintaining the quality of listing application documents and prospectus disclosures.

Ms. Katherine Ng, Head of Listing at HKEX, commented: “HKEX is committed to continuously enhancing the efficiency and competitiveness of Hong Kong’s listing regime while maintaining rigorous regulatory standards and protecting the public interest. With the support of the SFC, this extension builds upon the enhanced listing application timetable introduced jointly by HKEX and the SFC in October 2024, providing applicants with greater flexibility in managing listing timelines and supporting a more focused and efficient application process.”

4.    Continuing Listing Reforms and Strengthening Hong Kong’s Position as an International Financial Centre

The extension of the validity period for new listing applications represents another significant reform initiative following the enhanced timetable for new listing applications jointly announced by the SFC and the Stock Exchange in October 2024. The 2024 enhancements established clearer regulatory feedback timelines and review milestones, categorising listing applications into three different scenarios. The enhanced timetable was intended to enable most new listing applications to complete the regulatory review process within the existing six-month application validity period.

The latest measure doubles the validity period to twelve months, which is expected to reduce the need for re-submissions and extensive updating of application documents caused by application lapses. It also provides applicants with additional time to address regulatory comments and prepare listing documents.

Throughout the listing application process, applicants, sponsors and their advisers should continue to closely monitor the progress of their applications, promptly report material developments to regulators, and submit realistic timetables. Sponsors are expected to exercise due skill, care and diligence when establishing reasonable timelines, taking into account the time required by regulators to review and complete their assessments. Given the extended application validity period, the timing assumptions under the enhanced review timetable may be adjusted appropriately by reference to the latest progress updates and timetables provided by applicants and their sponsors.

5.    Conclusion

The Stock Exchange’s decision to extend the validity period of new listing applications is a practical response to market demand. In today’s increasingly complex market environment, companies preparing for IPOs face greater uncertainty, and a longer application validity period will help alleviate timing pressures and avoid the need to re-submit substantial volumes of updated materials simply because an application has expired.

The new measure should also ease the workload of sponsors and professional advisers, enabling them to devote more attention to the quality of application materials and prospectus disclosures. Overall, the change reflects market realities and further enhances Hong Kong’s competitive position as an efficient, sophisticated and internationally recognised financial centre.

The introduction of the Temporary Waiver marks another important step by HKEX in refining its listing framework and strengthening market competitiveness. It is expected to have a positive and far-reaching impact on Hong Kong’s IPO market.

Please contact our Partner Mr. Rodney Teoh for any enquiries or further information.

This news update is for information purposes only. Its content does not constitute legal advice and should not be treated as such. Stevenson, Wong & Co. will not be liable to you in respect of any special, indirect or consequential loss or damage arising from or in connection with any decision made, action or inaction taken in reliance on the information set out herein.